Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Pharmacoeconomics - Open|December 23, 2025
Potential Economic Value of Multi-cancer Early Detection Testing Under Differential Cost Trends for Cancer Screening and ManagementAnuraag R Kansal, Ali Tafazzoli, Weicheng Ye, et al.Brain Research. Molecular Brain Research|September 15, 2004
The endocytotic pathway is required for increased A beta 42 secretion during apoptosisChhinder P Sodhi, Srinivas Rampalli, Ruth G Perez, et al.JCO Oncology Practice|April 21, 2021
National Maintenance Cost for Precision Diagnostics Under the Verifying Accurate Leading-Edge In Vitro Clinical Test Development (VALID) Act of 2020Richard Huang, Laura Lasiter, Adam Bard, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 11, 2024
Regulatory Aspects of Artificial Intelligence and Machine LearningLiron Pantanowitz, Matthew Hanna, Joshua Pantanowitz, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2012
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohortsBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancerDavid R Parkinson, Robert T McCormack, Susan M Keating, et al.BMC Bioinformatics|July 20, 2005
Microarray scanner calibration curves: characteristics and implicationsLeming Shi, Weida Tong, Zhenqiang Su, et al.BMC Bioinformatics|July 20, 2005
Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essentialLeming Shi, Weida Tong, Hong Fang, et al.Science Translational Medicine|March 15, 2013
Regulatory and reimbursement innovationRachel A Lindor, Scott J Allocco, Lee Cheatham, et al.Pageof 5